Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)

INCLUSION CRITERIA: * Subjects seropositive for human immunodeficiency virus; * In the investigator's judgment, a high probability of 5 year survival and compliance with the study visit schedule; * Initiating SCULPTRA treatments; * Ability to comprehend and sign an informed consent document prior to study enrollment. * No waiver, prospective or retrospective, to deviate in any way from the inclusion/exclusion criteria for clinical study subjects, defined in the study protocol, can be granted to clinical investigators. EXCLUSION CRITERIA * Any active skin inflammation or infection in or near the treatment area; * Any hypersensitivity to the components of SCULPTRA * Previous treatment with SCULPTRA or any other product for facial lipoatrophy; * Pregnancy or breastfeeding or anticipating becoming pregnant during the study period; and * Any other excluding factors that, according to the investigator's judgment, would preclude enrollment in the study. * No waiver, prospective or retrospective, to deviate in any way from the inclusion/exclusion criteria for clinical study subjects, defined in the study protocol, can be granted to clinical investigators.